文献速递腹部CT

在肝硬化患者进行CT监测时提供常规肝脏体积评估是否具有附加价值

Does providing routine liver volume assessment add value when performing CT surveillance in cirrhotic patients?
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

该研究纳入584例连续接受腹部CT监测肝细胞癌的肝硬化患者及50例年龄、性别、种族和BMI匹配的无肝病对照,从CT测量总肝体积、功能性肝体积和肝段体积,随访至死亡、肝移植或2016年7月31日研究截止。结果显示肝硬化患者总肝体积和功能性肝体积显著低于对照,且总肝体积和功能性肝体积是死亡率的独立预测因素,作者认为常规监测CT时提供这些数据可能有附加价值。

要点

  • 肝硬化患者总肝体积和功能性肝体积显著低于无肝病对照。
  • 有肝性脑病的患者总肝体积和功能性肝体积显著低于无肝性脑病者(p=0.002)。
  • 总肝体积和功能性肝体积是肝硬化患者死亡率的独立预测因素。

核心结论

  • 基线肝脏体积是肝硬化患者死亡率的独立预测因素。
  • 在常规监测CT扫描时提供肝脏体积数据可能具有重要的附加价值。
  • 需要进一步研究验证这些发现并更好地理解其临床效用。

研究设计与样本

  • 研究纳入584例连续接受腹部CT监测肝细胞癌的肝硬化患者和50例年龄、性别、种族和BMI匹配的无肝病对照。
  • 从CT图像测量总肝体积、功能性肝体积和肝段体积(单位cm³)。
  • 肝硬化受试者随访至死亡、肝移植或2016年7月31日研究截止日期。
  • 生存数据采用log-rank统计评估,独立生存预测因素采用Cox风险模型分析。

关键影像表现/征象

  • 肝硬化患者总肝体积、功能性肝体积及除第1、6、7段外的肝段体积均显著低于对照。
  • 有肝性脑病的患者总肝体积和功能性肝体积显著低于无肝性脑病者(p=0.002)。

诊断标准与关键数值

  • 中位随访1145天期间,112例(19%)接受肝移植,131例(23%)死亡。
  • 存活者总肝体积为1740 vs 肝移植者1529 vs 死亡者1486,功能性肝体积为1691 vs 1487 vs 1444(p<0.0001)。
  • Cox回归模型中,年龄、MELD评分、总肝体积或功能性肝体积是死亡率的独立预测因素。

临床应用与阅片要点

  • 作者认为在常规监测CT时提供肝脏体积数据可能有用,可作为重要的附加价值。
  • 作者指出需要进一步研究验证这些发现并更好地理解其临床效用。

局限性

  • 原文结论指出需要进一步研究验证这些发现并更好地理解其临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The measurement of liver volume (LV) is considered to be an effective prognosticator for postoperative liver failure in patients undergoing hepatectomy. It is unclear whether LV can be used to predict mortality in cirrhotic patients.

METHODS: We enrolled 584 consecutive cirrhotic patients who underwent computerized topography (CT) of the abdomen for hepatocellular carcinoma surveillance and 50 age, gender, race, and BMI-matched controls without liver disease. Total LV (TLV), functional LV (FLV), and segmental liver volume (in cm3) were measured from CT imaging. Cirrhotic subjects were followed until death, liver transplantation, or study closure date of July 31, 2016. The survival data were assessed with log-rank statistics and independent predictors of survival were performed using Cox hazards model.

RESULTS: Cirrhotic subjects had significantly lower TLV, FLV, and segmental (all except for segments 1, 6, 7) volume when compared to controls. Subjects presenting with hepatic encephalopathy had significantly lower TLV and FLV than those without HE (p = 0.002). During the median follow-up of 1145 days, 112 (19%) subjects were transplanted and 131 (23%) died. TLV and FLV for those who survived were significantly higher than those who were transplanted or dead (TLV:1740 vs. 1529 vs. 1486, FLV 1691 vs. 1487 vs. 1444, p < 0.0001). In the Cox regression model, age, MELD score, TLV, or FLV were independent predictors of mortality.

CONCLUSION: Baseline liver volume is an independent predictor of mortality in subjects with cirrhosis. Therefore, it may be useful to provide these data while performing routine surveillance CT scan as an important added value. Further studies are needed to validate these findings and to better understand their clinical utility.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Patel M, Puangsricharoen P, Arshad HMS, et al. Does providing routine liver volume assessment add value when performing CT surveillance in cirrhotic patients? Abdom Radiol (NY). 2019. PMID: 31359098. doi:10.1007/s00261-019-02145-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。